Treatment of Mid-Life-Related Mood Disorders

NCT00001487 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Depressive Disorder
Mood Disorder

Interventions

DRUG: Dehydroepiandrosterone

Sponsor

National Institute of Mental Health (NIMH)